DNMT3A and Alzheimer disease: In order to verify whether stimulation of AD-MSCs growth by the HGC/bFGF combination treatment is correlated with gene expression of cellular senescence, we assessed SIRT1, DNMT1, DNMT3B, DNMT3A, p21, and p53 mRNA levels by using quantitative real-time PCR (Figure 6).